HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

EWS/Fli-1 chimeric protein is a transcriptional activator.

Abstract
Fli-1, an ets related gene, was found to be rearranged in 75% of erythroleukemias induced by Friend murine leukemia virus. We have shown previously that the Fli-1 gene codes for a sequence specific transcriptional activator which contains two autonomous transcriptional activation domains, one at the amino terminal region and the other at the carboxy terminal region. Recently human Fli-1 gene was shown to be involved in Ewing's sarcoma and related subtypes of primitive neuroectodermal tumors which share t(11;22) (q24;q12) chromosome translocation. In these tumors the carboxyl terminal region of Fli-1 was found to be fused with the amino terminal region of a putative RNA binding protein, EWS. Because part of the amino terminal transcriptional activation domain of Fli-1 was replaced with the amino terminal domain of the EWS (NTD-EWS) which shares homology with RNA polymerase II, it was speculated that NTD-EWS may interfere with RNA pol II function. Alternatively, NTD-EWS could also contribute to the transcriptional activation function of EWS/Fli-1 chimeric protein by providing either a modulatory/regulatory domain or a novel transcriptional activation domain. Here we show that EWS/Fli-1 chimeric protein functions as a transcriptional activator. Deletion analysis reveals that the EWS domain functions as a modulatory/regulatory domain for the transcriptional activation properties of the carboxy terminal transcriptional activation domain of EWS/Fli-1. We therefore propose that replacement of the amino terminal transcriptional activation domain of the Fli-1 protein with the regulatory domain of NTD-EWS results in the activation of the carboxy terminal transcriptional activation domain of Fli-1 which may be the molecular mechanism involved in these human tumors.
AuthorsT Ohno, V N Rao, E S Reddy
JournalCancer research (Cancer Res) Vol. 53 Issue 24 Pg. 5859-63 (Dec 15 1993) ISSN: 0008-5472 [Print] United States
PMID7503813 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • DNA, Complementary
  • DNA-Binding Proteins
  • Fli1 protein, mouse
  • Heterogeneous-Nuclear Ribonucleoproteins
  • Nuclear Proteins
  • Proto-Oncogene Protein c-fli-1
  • Proto-Oncogene Proteins
  • RNA-Binding Protein EWS
  • RNA-Binding Proteins
  • Recombinant Fusion Proteins
  • Ribonucleoproteins
  • Trans-Activators
Topics
  • 3T3 Cells
  • Animals
  • DNA, Complementary (isolation & purification)
  • DNA-Binding Proteins (genetics, physiology)
  • Heterogeneous-Nuclear Ribonucleoproteins
  • Humans
  • Mice
  • Nuclear Proteins (physiology)
  • Proto-Oncogene Protein c-fli-1
  • Proto-Oncogene Proteins
  • RNA-Binding Protein EWS
  • RNA-Binding Proteins (physiology)
  • Recombinant Fusion Proteins (physiology)
  • Ribonucleoproteins (physiology)
  • Sarcoma, Ewing (genetics)
  • Trans-Activators (genetics, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: